Entering text into the input field will update the search result below

Akers Biosciences reports Q2 results

Aug. 14, 2018 4:37 PM ETMyMD Pharmaceuticals, Inc. (MYMD) StockBy: Pranav Ghumatkar, SA News Editor2 Comments
  • Akers Biosciences (AKER): Q2 Net loss of $2.07M
  • Revenue of $0.53M (-50.5% Y/Y)
  • Shares -12.11%.
  • Press Release

Recommended For You

About MYMD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MYMD--
MyMD Pharmaceuticals, Inc.